Company Info
Phone(650) 525-5535
Year Established
2015
Ticker
TERN
Exchange
NASDAQ
Contacts
Amy Burroughs, M.B.A.CEO
Erin Quirk, M.D.
President, Head of R&D
Mark Vignola, Ph.D.
CFO
Bryan Yoon, Esq.
COO & General Counsel
Emil Kuriakose, MD
CMO, Oncology
Company Description
Terns Pharmaceuticals is an emerging global leader in the development of molecularly-targeted drugs and combination therapies to treat liver diseases.
